A simple body awareness program may help children with intellectual disabilities move better and do more in daily life

NCT ID NCT07729163

First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time

Summary

This trial tests whether adding a structured Body Awareness Training (BAT) program to standard physiotherapy can improve motor skills, everyday activity performance, and participation in children aged 8 to 15 with mild to moderate intellectual disabilities. Participants receive either conventional physiotherapy alone or physiotherapy plus 30 minutes of BAT per session for six weeks. The study measures changes in motor proficiency, self-perceived performance in daily tasks, and achievement of personalized functional goals.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a structured Body Awareness Training program added to conventional physiotherapy
What this could lead to
If it works, this low-cost, adaptable training could become a standard add-on to physiotherapy for children with intellectual disabilities, improving their coordination and daily life participation.
What could go wrong
This is a small, single-center trial with 41 children. Results may not apply to all children with intellectual disabilities, and the training requires consistent delivery to be effective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTELLECTUAL DISABILITY, MILD TO MODERATE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cyprus International University

    Mersin, Mersin, 99040, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.